Recombinant papillomavirus vaccines
US5888516A · kind A · utility
10Cited by
2References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 22, 1997 |
| Grant date | Mar 30, 1999 |
| Priority date | — |
| Expiry date | Oct 22, 2017 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S977/918
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Recombinant expression vectors encoding the L1 and L2 proteins of papillomavirus, methods of making and using the recombinant proteins and purified virus-like particles comprised of the recombinant proteins are provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.